Abbott (ABT) Tops Q1 EPS by 26c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq on track for record closing highs as focus turns to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $98.23 -1.87%
Revenue Growth %: +14.2%
Financial Fact:
Dilutive Common Stock Options and Awards (in shares): 0
Today's EPS Names:
TMQ, OMH, AEHR, More
Revenue Growth %: +14.2%
Financial Fact:
Dilutive Common Stock Options and Awards (in shares): 0
Today's EPS Names:
TMQ, OMH, AEHR, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q1 EPS of $1.73, $0.26 better than the analyst estimate of $1.47. Revenue for the quarter came in at $11.9 billion versus the consensus estimate of $11.02 billion.
GUIDANCE:
Abbott maintains FY 2022 EPS guidance of 'at least' $4.70.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lamb Weston (LW) Tops Q1 EPS by 15c ; Offers Guidance
- Lamb Weston shares jump on strong quarterly results
- Abbott receives FDA approval for new CardioMEMS HF System capabilities that help patients engage in the care of their heart condition
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
